CHARACTERIZATION OF SYSTEMIC LUPUS-ERYTHEMATOSUS IN PATIENTS IN UAE

被引:14
作者
ALATTIA, HM
GEORGE, S
机构
[1] Department of Internal Medicine, Mafraq Hospital, Abu Dhabi
关键词
SLE; DS (DNA) ANTIBODIES; POPULATION SURVEY; MIDDLE EAST;
D O I
10.1007/BF02214938
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Twenty-eight SLE patients (Arabs and Asians) in the UAE were studied in this report. The F:M ratio was markedly high; 27:1 in the group as a whole and 21:1 among Arabs. Local patients (Emirians) developed the disease at an earlier age compared to their expatriate Arab compatriots. Arthropathy occurred in 86% and nephropathy in 43% of cases. Next in frequency were leucopenia, mucocutaneous manifestations and serositis. Apart from lupus headache, the other neuro-psychiatric LE were uncommon or not encountered. Anti-cardiolipin syndrome, Sneddon's syndrome, shrunken lung syndrome, sicca complex, thyrotoxicosis and myasthenia gravis were also present in this small group of patients. Their presence reflects the marked heterogeneity displayed by the disease irrespective of the number of cases involved. An unusually high prevalence of anti ds (DNA) antibodies (92.5%) as compared to ANF (82.5%) was detected (P=NS). Anti-Sm antibody occurred in 30% of cases particularly in those patients with lymphadenopathy and fever. There was a relative paucity in the prevalence of anti RNP, Ro and La antibodies in this group. Differences with and similarities to previous reports concerning other populations are also presented.
引用
收藏
页码:171 / 175
页数:5
相关论文
共 23 条
  • [1] Blaese R.M., Grayson J., Stemberg A.D., Increased immunoglobulin-secreting cells in the blood of patients with systemic lupus erythematosus, Am J Med, 69, pp. 345-350, (1980)
  • [2] Balow J.E., Tsokos G.C., T and B lymphocyte function in patients with lupus nephritis: correlation with renal pathology, Clin Nephrol, 21, pp. 93-97, (1984)
  • [3] Rothfield N.F., Systemic lupus erythematosus: Clinical aspects and treatment, Arthritis and Allied Conditions, pp. 911-935, (1985)
  • [4] Fessel W.J., Epidemiology of systemic lupus erythematosus, Systemic Lupus Erythematosus: Rheumatic Clinics of North America, pp. 15-23, (1988)
  • [5] Ballou S.P., Khan M.A., Kushner I., Clinical features of systemic lupus erythematosus: Differences related to race and age, Arthritis Rheum, 1, pp. 55-60, (1982)
  • [6] Ward M.M., Studenski S., Clinical manifestations of systemic lupus erythematosus. Identification of racial and socioeconomic influences, Arch Intern Med, 1, pp. 849-853, (1990)
  • [7] Kaslow R.A., High rate of death caused by systemic lupus erythematosus among U.S. residents of Asian descent, Arthritis Rheum, 25, pp. 414-418, (1982)
  • [8] Tan E.M., Cohen A.S., Fries J.F., The 1982 revised criteria for the classification of systemic lupus erythematosus, Arthritis Rheum, 25, pp. 1271-1277, (1982)
  • [9] Wang F., Management of lupus nephritis, Medicine Digest, 18, pp. 8-13, (1992)
  • [10] Kippel J.H., Treatment of systemic lupus erythematosus, Primer on the Rheumatic Diseases, pp. 107-110, (1988)